Eywa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EYWA, and what generic and branded alternatives to EYWA drugs are available?
EYWA has six approved drugs.
Drugs and US Patents for Eywa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eywa | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 207863-001 | Feb 4, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Eywa | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 207863-003 | Feb 4, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Eywa Pharma | ALOSETRON HYDROCHLORIDE | alosetron hydrochloride | TABLET;ORAL | 211621-002 | Sep 16, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.